Clinical Trial Update: Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating pembrolizumab, binimetinib, and bevacizumab in patients with refractory colorectal cancer has completed. Results were posted on Decem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Binimetinib (binimetinib)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-12-23